HROW Harrow, Inc. Net earnings per share (EPS TTM)

Symbol and logo of brand Harrow (HROW)

The rolling net income per share snapshot for Harrow, Inc. (HROW) on GURU.Markets demonstrates the efficiency of its licensing and direct sales model for ophthalmological products. The value -0.78 reflects the metric's baseline, confirming the brand's expansion through acquisitions and new approvals. Meanwhile, the financial result relies on cataract surgery volumes and current prescription manufacturing legislation.

HROW Harrow Corp Net earnings per share for the last four quarters (07/04/2022 - 11/14/2026)

Summary analytical data breakdowns for Harrow Corp (HROW)

- share price and expert price forecast:
Stock Quotes Harrow Corp|HROW - Average Forecast Price
- market capitalization data:
Market Capitalization Harrow, Inc.|HROW - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Harrow|HROW - Book Valuation of Business|Market Capitalization to Book Value Ratio harrowinc.com|HROW - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Harrow, Inc.|HROW - Long-Term Debt to Capital|Short-Term Debt to Equity Harrow, Inc.|HROW - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Harrow Corp|HROW - Company Long-Term Loans and Borrowings|Company Short-Term Debt Harrow|Quick Liquidity Indicator harrowinc.com
- earnings and multiples data:
HROW - Net Income|Future Profit Harrow, Inc.|HROW - Company Value to Net Income|Forward P/E Multiple Harrow Corp|HROW - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Harrow|HROW - Operating profit before amortization|Net earnings per share (EPS TTM) Harrow|HROW - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months harrowinc.com|HROW - Expected net earnings per share growth this year|Earnings growth forecast for next year Harrow, Inc.
- total revenue and sales volume data:
HROW - Company Sales Revenue|Company Projected Revenue Harrow|HROW - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Harrow, Inc.
General company analysis:HROW - Harrow
Manufactured products of Harrow Health

Amid intense competition with medical behemoths and the expansion of generics, Harrow, Inc. (HROW) is forced to optimize margins to maintain its market position. The trend in fundamental TTM earnings per share, which aggregates annual data without quarterly gaps, allows for a real-time assessment of capital generation efficiency per share, confirming the business's resilience in the face of industry risks and market traps.

Competing companies

Alcon Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bausch + Lomb|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Apellis Corp (APLS)|Earnings per share for the last twelve months Belite Bio|ocutx.com (OCUL) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months VRDN (Viridian Therapeutics, Inc.)|Earnings per share for the last twelve months LENZ (LENZ Therapeutics)|Earnings per share for the last twelve months Oculis AG OCS|EyePoint Pharma (EYPT) - Net earnings per one share for the last twelve months|kodiak.com - Net earnings per share (EPS TTM)|ALDX (aldeyra.com) - Earnings per share for the last 12 months|KALA: Net earnings per share (EPS TTM)|Opus Genetics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months OKYO|ADVM: Earnings per share for the trailing year|Earnings per share for the last twelve months Outlook Therapeutics Inc (OTLK)|Net earnings per share for the last four quarters Clearside Biomedical|NovaBay Pharmaceuticals - Net earnings per share for the last 12 months|KPRX (Kiora Pharma) - Earnings per one share for the last 12 months|ALIM: Net earnings per share for the last 12 months|EYEN - Net earnings per share (EPS TTM)|GHSI (Guardion Health Science) - Net earnings per share for the last 12 months|ocuphire.com - Earnings per share for the trailing year|OPT (Opthea Ltd) - Net earnings per share (EPS TTM)